Previous close | 1.7500 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 115.00 |
Expiry date | 2023-04-21 |
Day's range | 1.7500 - 1.7500 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Biogen Inc. (BIIB) closed at $274.01 in the latest trading session, marking a +1.39% move from the prior day.
The BIIB080 Phase 1b clinical study is the first to show a reduction of this magnitude in tau PET across brain regionsPhase 1b Study of BIIB080 showed dose-dependent and sustained reduction of tau protein (CSF t-tau and p-tau181) in the cerebral spinal fluid (CSF) throughout the open-label long-term extension (LTE)Neurofibrillary tangles in the brain are composed of tau proteins and are a key pathology associated with Alzheimer’s disease1 CAMBRIDGE, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- Biog
Biogen Inc. (BIIB) closed at $269.98 in the latest trading session, marking a -0.02% move from the prior day.